Rigel Pharmaceuticals Inc
NASDAQ:RIGL
Rigel Pharmaceuticals Inc
Pre-Tax Income
Rigel Pharmaceuticals Inc
Pre-Tax Income Peer Comparison
Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors
Company | Pre-Tax Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Rigel Pharmaceuticals Inc
NASDAQ:RIGL
|
Pre-Tax Income
-$19.8m
|
CAGR 3-Years
-27%
|
CAGR 5-Years
21%
|
CAGR 10-Years
14%
|
|
Abbvie Inc
NYSE:ABBV
|
Pre-Tax Income
$7.5B
|
CAGR 3-Years
22%
|
CAGR 5-Years
9%
|
CAGR 10-Years
3%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Pre-Tax Income
$1.1B
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-33%
|
CAGR 10-Years
-16%
|
|
Amgen Inc
NASDAQ:AMGN
|
Pre-Tax Income
$4.3B
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-2%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Pre-Tax Income
$4.8B
|
CAGR 3-Years
13%
|
CAGR 5-Years
47%
|
CAGR 10-Years
N/A
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Pre-Tax Income
$4B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
10%
|
CAGR 10-Years
18%
|
See Also
What is Rigel Pharmaceuticals Inc's Pre-Tax Income?
Pre-Tax Income
-19.8m
USD
Based on the financial report for Mar 31, 2024, Rigel Pharmaceuticals Inc's Pre-Tax Income amounts to -19.8m USD.
What is Rigel Pharmaceuticals Inc's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 10Y
14%
Over the last year, the Pre-Tax Income growth was 56%. The average annual Pre-Tax Income growth rates for Rigel Pharmaceuticals Inc have been -27% over the past three years , 21% over the past five years , and 14% over the past ten years .